[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558036":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":35,"locations":45,"responsibleParty":69,"collaborators":29,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":29,"eligibilityCriteria":79,"healthyVolunteers":80,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":29,"studyType":87,"phases":88,"briefSummary":91,"conditions":92,"keywords":94,"overallStatus":48,"whyStopped":29,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"Cairo University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ketofol Group","EXPERIMENTAL","Five minutes after induction; Ketofol (ketamine to propofol ratio 1:4) will be infused at a rate of 0.6 ml\u002Fkg\u002Fhr. Ketofol will be prepared by adding 40 mg of ketamine to 160 mg of propofol and diluted to 20 ml with normal saline 0.9%.",[13],"Drug: Ketamine",{"label":15,"type":10,"description":16,"interventionNames":17},"Dexmedetomidine","Five minutes after securing the airway, dexmedetomidine infusion will be started at a rate of 0.2 mcg\u002Fkg\u002Fhr.",[18],"Drug: Dexmedetomidine",[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Ketamine","continous infusion during surgery",[9],[26],"propofol",{"type":21,"name":15,"description":23,"armGroupLabels":28,"otherNames":29},[15],null,[31],{"name":32,"affiliation":33,"role":34},"Karim K Fahim","Professor of Anesthesia, Pain management and Surgical ICU Faculty of Medicine, Cairo University.","STUDY_DIRECTOR",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":29,"email":40},"Muhammad Kh Ibrahim","CONTACT","+201032170260","dr.mki26413@gmail.com",{"name":42,"role":38,"phone":43,"phoneExt":29,"email":44},"Mohamed El Abdelfatah","+201272288695","mohyaseen2@gmail.com",[46,58],{"facility":47,"status":48,"city":49,"state":29,"zip":29,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":29},"Abu Elresh Hospitals ( Cairo university )","RECRUITING","Cairo","Egypt","EG",{"type":53,"coordinates":54},"Point",[55,56],31.24967,30.06263,{"lat":56,"lon":55},{"facility":59,"status":60,"city":49,"state":29,"zip":29,"country":50,"countryCode":51,"cosmosGeoPoint":61,"geoPoint":63,"contacts":64},"Abu ElResh hospital","NOT_YET_RECRUITING",{"type":53,"coordinates":62},[55,56],{"lat":56,"lon":55},[65],{"name":66,"role":38,"phone":67,"phoneExt":29,"email":68},"Karim M Assem, MD","+201003878369","drknawwar@yahoo.com",{"type":70,"investigatorFullName":71,"investigatorTitle":72,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"PRINCIPAL_INVESTIGATOR","Muhammad Khalaf","principle investigator","100558036","phase-1-ketofol-versus-dexmedetomidine-for-prevention-of-emergence-delirium-in-pediatric-patients-undergoing-squint-surgeries-100558036",false,"NCT06545890","Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries","Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries: A Randomized Controlled Study.","Inclusion Criteria:\n\n* • All pediatric patients aged 2 to 6 years.\n\n  * Both sexes.\n  * ASA physical status I and II.\n  * Patients undergoing squint surgery.\n\nExclusion Criteria:\n\n* • Refusal of parents.\n\n  * Patient sensitivity to any of the study medications.\n  * Known neurological disease that can affect the assessment of ED postoperatively.",true,"ALL","2 Years","6 Years",{"count":85,"type":86},46,"ESTIMATED","INTERVENTIONAL",[89,90],"PHASE1","PHASE2","The aim of the study is to compare the effectiveness of ketofol for the prevention of emergence delirium in pediatric patients undergoing squint surgery, in comparison to dexmedetomidine.",[93],"Emergence Delirium",[95,96,97,98],"ketofol","dexmedetomidine","squint surgeries","children","2024-08-16",{"date":101,"type":102},"2024-08-20","ACTUAL",{"date":104,"type":102},"2024-08-10",{"date":106,"type":86},"2024-11-10",{"name":5,"class":6},2]